Clinically Studied Strains

Studied in human clinical trials: B. longum BB536, L. rhamnosus R0011 and L. helveticus R0052 are well characterized and have been shown to interact via multiple mechanisms of action with the intestinal tract and the microbial ecosystem within it.* These strains have been clinically shown to improve the properties of the intestinal microflora, promote intestinal health and support immune response.*